Skinvisible (SKVI) Share-based Compensation Growth (1y) (2011 - 2017)
Powered by 
Analysis
Skinvisible (SKVI) Share-based Compensation Growth (1y) (2011 - 2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.02 Bn | 629.26 Bn | 17.26 Bn | -119.48% |
| 2 | AbbVie | 443.38 Bn | 436.81 Bn | 12.70 Bn | -7.26% |
| 3 | Merck | 368.22 Bn | 361.07 Bn | 12.21 Bn | 37.96% |
| 4 | Novartis Ag | 270.16 Bn | 262.47 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.63 Bn | 146.93 Bn | 10.94 Bn | 22.66% |
| 6 | Sanofi | 52.92 Bn | 45.54 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.49 Bn | 44.49 Bn | - | - |
| 8 | Incyte | 25.22 Bn | 20.69 Bn | 1.57 Bn | 4.11% |
| 9 | United Therapeutics | 21.17 Bn | 18.51 Bn | 683.80 Mn | -49.74% |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 391.47% |
| Mar 31, 2017 | -82.02% |
| Dec 31, 2016 | 146.02% |
| Mar 31, 2016 | 1,416.42% |
| Dec 31, 2015 | -78.63% |
| Sep 30, 2014 | 214.88% |
| Dec 31, 2012 | 94.06% |
| Dec 31, 2011 | -44.10% |
| Sep 30, 2011 | 4.35% |